Invitrogen Corp, Carlsbad, Calif, a provider of essential life science technologies for research, production and diagnostics, has signed an exclusive US distribution agreement with Biocare Medical LLC, for the new SPOT-Light HER2 CISH Kit. The kit received US Food and Drug Administration premarket approval in July, as an aid in the assessment of breast cancer patients for whom trastuzumab (Herceptin) treatment is being considered.
Read More
A look at today’s respiratory viral diagnostics
Read MoreQuest Diagnostics Inc, Madison, NJ, announces that it has been selected again to be part of the Dow Jones Sustainability (DJSI) World and North American Indexes. The company is in its fifth year on the World Index, first added in 2004, and has appeared on the North American Index since 2005.
Read More
Complex viral genetics and overlapping disease symptoms pose challenges
Read MoreThe US Food and Drug Administration have announced the approval of the vaccine Gardasil for the prevention of vaginal and vulvar cancer caused by Human Papillomavirus (HPV) types 16 and 18 in girls and women ages 9 to 26.
Read More